GNCC Capital Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

-555k

L-6.68%

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

GNCC Capital, Inc., operating through its subsidiary BioCann Pharma S.A.S., specializes in the production and marketing of pharmaceutical-grade CBD oils derived from cannabis. These products are distributed via established networks throughout Colombia and across the broader Latin American market. The parent company's headquarters are located in Las Vegas, Nevada.

Key people

Peter Voss

Chief Executive Officer · since 2014

Ted Blom

Director

Paula Victoria

Director · since 2019

URL

https://www.gncc-capital.com

IPO date

Nov 26, 2003

Employees

Domiciled in

Incorporated in

Legal address

C/O Corporation Service Company
1821 Logan Avenue
Cheyenne, WY 82001
US

Headquarters

244 5th Avenue
Suite 2525
New York, NY 10001
US

Previous name

GNCC Capital, Inc.

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2021‑09	2020‑09	2019‑09	2018‑09	2017‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT